Concepedia

Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.

Taner Demirer, S Rowley, CD Buckner, F R Appelbaum, K Lilleby, Rainer Storb, K Schiffman

Journal of Clinical Oncology · 1995 · 48 citations · 17 references

DOI

Abstract

These data suggest that Taxol and CY followed by rhG-CSF mobilizes PBSCs in patients with advanced breast and ovarian cancer more effectively than this regimen without Taxol.

References

17

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.8K citations

, , +13

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

William P. McGuire · Annals of Internal Medicine · 1989 · 1.1K citations

, , +16

Sequences of taxol and cisplatin: a phase I and pharmacologic study.

Eric K. Rowinsky, Mark R. Gilbert, William P. McGuire et al. · Journal of Clinical Oncology · 1991 · 431 citations

, , +15

Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor

Jack W. Singer, F R Appelbaum, K Lilleby et al. · Blood · 1993 · 374 citations · Full text

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

K Longin, F R Appelbaum, S Rowley et al. · British Journal of Haematology · 1994 · 292 citations

, , +18